Screen time and anxiety, global pain levels, d-dimer and DVT, and tertiary patients

Written By Christina Acosta

This week we look at infant screen time and anxiety, global pain levels, d-dimer and DVT, and tertiary patents on FDA approved drugs.

Program notes:

0:35 Global pain burden

1:35 Prevalence increased in 15 countries

2:35 Higher prevalence in older people but not consequence of aging

3:02 Tertiary patents

4:03 in the Orange Book

5:05 Prolonged patent protection and higher prices

6:07 Focused on high revenue products

6:50 Detecting DVT better

7:51 Age specific D-dimer cutoffs

8:51 Age and morbidity factors

9:23 Infant screen time and adolescent anxiety

10:24 Multiple intermediate assessments

11:24 Accelerates development

12:47 End

Christina Acosta
Next

Back pain, private equity and IVF clinics, EKGs and liver disease, and lay health workers